← Open Payments lookup

REIMUND SERAFICA: Open Payments

NPI 1245823863 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,701 in 63 payments from 9 companies in 2025. Trend: 2023 $25 · 2024 $1,653 · 2025 $1,701

Food & beverage: $1,701
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.18$606
ABBVIE INC.16$597
Vanda Pharmaceuticals Inc.14$218
Teva Pharmaceuticals USA, Inc.4$77
Supernus Pharmaceuticals, Inc.4$58
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$53
Collegium Pharmaceutical, Inc.2$45
Lundbeck LLC2$32
Alkermes, Inc.1$16

Products named: REXULTI, VRAYLAR, FANAPT, AUSTEDO XR, Qelbree, CAPLYTA, Jornay PM, ARISTADA.

Industry payments across NV — which companies pay providers there.